Concert Pharmaceuticals Inc

NASDAQ:CNCE  
4.00
-0.01 (-0.25%)
Earnings Announcements

Concert Pharmaceuticals Reports Q1 Loss Per Share $0.67

Published: 05/04/2021 11:40 GMT
Concert Pharmaceuticals Inc (CNCE) - Concert Pharmaceuticals Reports First Quarter 2021 Financial Results.
Q1 Loss per Share $0.67.
Revenue is expected to be $0.5 Million
Adjusted EPS is expected to be -$0.72

Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.77

More details on our Analysts Page.